M&A Deal Summary

Natus Acquires Micromed

On December 2, 2022, Natus acquired medical products company Micromed from ArchiMed

Acquisition Highlights
  • This is Natus’ 11th transaction in the Medical Products sector.
  • This is Natus’ 1st transaction in Italy.

M&A Deal Summary
Date 2022-12-02
Target Micromed
Sector Medical Products
Buyer(s) Natus
Sellers(s) ArchiMed
Deal Type Add-on Acquisition

Target

Micromed

Treviso, Italy
Micromed is a medical device company delivering solutions in Neurophysiology to over 78 countries worldwide. Partnering with hospitals, sleep labs, and research centers on a global scale, the company manufactures and markets high-quality, cost-effective, and clinically relevant neurodiagnostic hardware and software to neurologists, clinicians, and researchers for use on adult and pediatric patients. Its product portfolio ranges from Routine, Ambulatory, and Video EEG to electrocorticography (ECoG), stereoelectroencephalography (SEEG), PSG, evoked potentials (EP), EMG and ICU multimodal monitoring solutions for clinical and research. Micromed was formed in 1982 and is based in Treviso, Italy.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Natus

Middleton, Wisconsin, United States
Category Company
Founded 1987
Sector Medical Products
Revenue 473M USD (2021)
DESCRIPTION

Natus is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Natus was founded in 1987 and is based in Pleasanton, California.

DEAL STATS #
Overall 12 of 12
Sector (Medical Products) 11 of 11
Type (Add-on Acquisition) 9 of 9
Country (Italy) 1 of 1
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-23 Babybe

Stuttgart, Germany

Babybe GmbH offers a new way to remotely connect a mother and her baby in the neonatal intensive care unit (NICU). With this technology, mother and baby are connected in real-time through heartbeat, breathing, and vocal sound using an active mattress system. Babybe is based in Stuttgart, Germany.

Buy -

Seller(S) 1

SELLER

ArchiMed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 8.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

DEAL STATS #
Overall 6 of 9
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 5 of 8
Country (Italy) 3 of 3
Year (2022) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-07 PlasmidFactory

Bielefeld, Germany

PlasmidFactory is a contract manufacturing organization (CMO) for plasmid and minicircle DNA. The company manufactures largescale plasmid DNA in three different grades: high-quality grade that is used in mRNA vaccine production for commercial purposes, ccc grade and research grade that are used for transfections and virus production in preclinical applications and early research studies. The customer base includes pharmaceutical and small to large biotech companies as well as research institutes. PlasmidFactory was founded in 2000 and is based in Bielefeld, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-07 Xpress Biologics

Milmort, Belgium

Xpress Biologics is a developer of expression systems and manufacturing processes for the production of plasmid DNA and protein therapeutics. Xpress Biologics was founded in 2014 and is based in Milmort, Belgium.

Sell -
Mergr

Product

Company

Legal